Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z4QJ
|
|||
| Drug Name |
PMID25623274-Compound-WO2014132220C1
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pulmonary arterial hypertension [ICD-11: BB01.0; ICD-9: 416] | Patented | [1] | |
| Company |
NOVARTIS AG BRUCE, Ian CHAMOIN, Sylvie COLLINGWOOD, Stephen Paul FURET, Pascal FURMINGER, Vikki LEWIS, Sarah LOREN, Jon LV, Lin MOLTENI, Valentina SAUNDERS, Alex Michael SHAW, Duncan TURNER, Roy YEH, Vince
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Platelet-derived growth factor receptor (PDGFR) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Platelet-derived growth factor receptor (PDGFR) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Evaluation of WO-2014132220, selective PDGFR inhibitors for the treatment of pulmonary arterial hypertension.Expert Opin Ther Pat. 2015 Apr;25(4):493-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.